NCT01673217 2022-08-01Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal CancerRoswell Park Cancer InstitutePhase 1 Completed18 enrolled